Intense management of diabetes mellitus: role of glucose control and antiplatelet agents (Q28168035)

The Journal of Clinical Pharmacology

Europe PubMed Central

title

Intense management of diabetes mellitus: role of glucose control and antiplatelet agents (English)

0 references

author name string

Sunder Mudaliar

series ordinal

1

0 references

language of work or name

English

0 references

publication date

April 2004

0 references

published in

0 references

volume

44

0 references

page(s)

414-22

0 references

issue

4

0 references

cites work

Diabetes and cardiovascular disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

The impact of diabetes on survival among patients with first myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Risk factors for sudden coronary death in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Diabetes and decline in heart disease mortality in US adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Glucose control and cardiovascular complications: the VA Diabetes Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Standards of medical care in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

The cardiovascular dysmetabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Insulin therapy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Blood glucose and platelet-dependent thrombosis in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Aspirin therapy in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Final report on the aspirin component of the ongoing Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

THE RELATIONSHIP OF CARDIOVASCULAR DISEASE TO HYPERGLYCEMIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Mortality among diabetics in a national sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota Heart Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

The UK Prospective Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Inf

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045

Effects of aspirin treatment on survival in non-insulin-dependent diabetic patients with coronary artery disease. Israeli Bezafibrate Infarction Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270004263045